Cart
sales@molnova.com
Selamectin (b)
CAS No. 165108-07-6
Selamectin (b)( —— )
Catalog No. M12522 CAS No. 165108-07-6
Selamectin is a topical parasiticide and antihelminthic used on dogs and cats, distributed by Zoetis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 106 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 260 | In Stock |
|
| 50MG | 389 | In Stock |
|
| 100MG | 575 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSelamectin (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionSelamectin is a topical parasiticide and antihelminthic used on dogs and cats, distributed by Zoetis.
-
DescriptionSelamectin is a topical parasiticide and antihelminthic used on dogs and cats, distributed by Zoetis. Selamectin disables parasites by activating glutamate-gated chloride channels at muscle synapses.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorGlutamate-gated chloride channels
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number165108-07-6
-
Formula Weight769.96
-
Molecular FormulaC43H63NO11
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESC[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N/O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)\C)O[C@@H]1C7CCCCC7
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dryden MW, et al. Parasit Vectors. 2013 Mar 25;6:80.
molnova catalog
related products
-
LY404187
LY404187 is a positive allosteric modulator of AMPA receptors.
-
KM02894
KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases.
-
(S)-MCPG
(S)-MCPG ((+)-MCPG) is a class I/II metabotropic glutamate receptors (mGluRs) antagonist that blocks spatial learning and long-term enhancement of the dentate gyrus in vivo in rats, and can be used to study neurological disorders.
